98 related articles for article (PubMed ID: 9224462)
1. Neovascular glaucoma developing after uncomplicated cataract surgery for heavily irradiated eyes.
Kwok SK; Leung SF; Ho PC; Gandhi S; Chen IN; Michon JJ; Lam DS; Lai JS
Ophthalmology; 1997 Jul; 104(7):1112-5. PubMed ID: 9224462
[TBL] [Abstract][Full Text] [Related]
2. Late retinal complications of radiation therapy for nasal and paranasal malignancies: relationship between irradiated-dose area and severity.
Takeda A; Shigematsu N; Suzuki S; Fujii M; Kawata T; Kawaguchi O; Uno T; Takano H; Kubo A; Ito H
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):599-605. PubMed ID: 10348290
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
[TBL] [Abstract][Full Text] [Related]
4. Neovascular glaucoma following pars plana vitrectomy for complications of diabetic retinopathy.
Wand M; Madigan JC; Gaudio AR; Sorokanich S
Ophthalmic Surg; 1990 Feb; 21(2):113-8. PubMed ID: 2330190
[TBL] [Abstract][Full Text] [Related]
5. Panretinal photocoagulation in the management of neovascular glaucoma.
Cashwell LF; Marks WP
South Med J; 1988 Nov; 81(11):1364-8. PubMed ID: 3187630
[TBL] [Abstract][Full Text] [Related]
6. Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma.
Ehlers JP; Spirn MJ; Lam A; Sivalingam A; Samuel MA; Tasman W
Retina; 2008 May; 28(5):696-702. PubMed ID: 18463512
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: safety and efficacy.
Eid TM; Radwan A; el-Manawy W; el-Hawary I
Can J Ophthalmol; 2009 Aug; 44(4):451-6. PubMed ID: 19606170
[TBL] [Abstract][Full Text] [Related]
8. Postoperative Hemorrhagic Occlusive Retinal Vasculitis: Expanding the Clinical Spectrum and Possible Association with Vancomycin.
Witkin AJ; Shah AR; Engstrom RE; Kron-Gray MM; Baumal CR; Johnson MW; Witkin DI; Leung J; Albini TA; Moshfeghi AA; Batlle IR; Sobrin L; Eliott D
Ophthalmology; 2015 Jul; 122(7):1438-51. PubMed ID: 25886796
[TBL] [Abstract][Full Text] [Related]
9. [Risk Factors and Preventive Effects of Laser Panretinal Photocoagulation for Neovascular Glaucoma after Ophthalmic Stereotactic Radiotherapy].
Ueda E; Yoshikawa H; Arakawa S; Kohno RI; Ohga S; Nakamura K; Ishibashi T; Sonoda KH
Nippon Ganka Gakkai Zasshi; 2016 Oct; 120(10):689-95. PubMed ID: 30088402
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab.
Olmos LC; Sayed MS; Moraczewski AL; Gedde SJ; Rosenfeld PJ; Shi W; Feuer WJ; Lee RK
Eye (Lond); 2016 Mar; 30(3):463-72. PubMed ID: 26681145
[TBL] [Abstract][Full Text] [Related]
11. Neovascular glaucoma following central retinal vein obstruction.
Magargal LE; Brown GC; Augsburger JJ; Parrish RK
Ophthalmology; 1981 Nov; 88(11):1095-101. PubMed ID: 6174914
[TBL] [Abstract][Full Text] [Related]
12. [Simultaneous pars plana vitrectomy and glaucoma drainage device implant].
Suárez-Fernández MJ; Gutiérrez-Díaz E; Julve San Martín A; Fernández-Reyes MF; Mencía-Gutiérrez E
Arch Soc Esp Oftalmol; 2010 Mar; 85(3):97-102. PubMed ID: 20619120
[TBL] [Abstract][Full Text] [Related]
13. [Vitreoretinal surgery in the treatment of neovascular glaucoma].
Psichias A; Bartz-Schmidt KU; Thumann G; Krieglstein GK; Heimann K
Klin Monbl Augenheilkd; 1999 Feb; 214(2):61-70. PubMed ID: 10218197
[TBL] [Abstract][Full Text] [Related]
14. Neovascular glaucoma: a retrospective review from a tertiary center in China.
Liao N; Li C; Jiang H; Fang A; Zhou S; Wang Q
BMC Ophthalmol; 2016 Jan; 16():14. PubMed ID: 26818828
[TBL] [Abstract][Full Text] [Related]
15. Role of intravitreal bevacizumab in neovascular glaucoma.
Gheith ME; Siam GA; de Barros DS; Garg SJ; Moster MR
J Ocul Pharmacol Ther; 2007 Oct; 23(5):487-91. PubMed ID: 17900231
[TBL] [Abstract][Full Text] [Related]
16. Neovascular glaucoma after proton beam therapy of choroidal melanoma: incidence and risk factors.
Riechardt AI; Pilger D; Cordini D; Seibel I; Gundlach E; Hager A; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2263-2269. PubMed ID: 28721444
[TBL] [Abstract][Full Text] [Related]
17. Ranibizumab Plus Combined Surgery for Treatment of Neovascular Glaucoma with Vitreous Hemorrhage.
Li XJ; Yang XP; Li QM; Wang YY; Lyu XB
Chin Med J (Engl); 2015 Aug; 128(15):2078-83. PubMed ID: 26228222
[TBL] [Abstract][Full Text] [Related]
18. Ischemic index and distribution of retinal capillary non-perfusion in neovascular glaucoma.
DeBoer C; Wong B; Ameri H
Front Biosci (Landmark Ed); 2022 Jan; 27(1):24. PubMed ID: 35090329
[TBL] [Abstract][Full Text] [Related]
19. Frequency and risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy.
Goto A; Inatani M; Inoue T; Awai-Kasaoka N; Takihara Y; Ito Y; Fukushima M; Tanihara H
J Glaucoma; 2013 Sep; 22(7):572-6. PubMed ID: 22407392
[TBL] [Abstract][Full Text] [Related]
20. Panretinal photocoagulation during cataract extraction in eyes with active proliferative diabetic eye disease.
West JA; Dowler JG; Hamilton AM; Boyd SR; Hykin PG
Eye (Lond); 1999 Apr; 13 ( Pt 2)():170-3. PubMed ID: 10450376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
